Endocannabinoid System Research: Cannabis Clinical Trials Overview
Phase 3 cannabis clinical trials provide critical evidence on the effectiveness of full-spectrum cannabis extracts for chronic low back pain. This research highlights sustained pain relief and safety outcomes in large participant groups. The trials…
`Endocannabinoid System RCT: Cannabis for Chronic Back Pain`
Clinical Takeaway In this phase 3 randomized controlled trial of 820 adults with chronic low back pain, VER-01, a full-spectrum cannabis extract, was evaluated against placebo over 12 weeks with extended follow-up periods reaching up to one year. The…
Dronabinol as an Adjunct for Reducing Pain
This dronabinol placebo-controlled trial explores synthetic THC as an adjunct for reducing chronic low back pain. The study focuses on safety and feasibility over 8 weeks. Results will inform future clinical guidelines for dronabinol use in pain…
PM Study Update: March 17, 2026 – Cannabis Clinical Trials
This PM Study Update covers 2026 cannabis clinical trials mental health research. It highlights important findings from recent clinical studies. The update provides valuable insights for clinicians and patients.
AM Study Update: Full-Spectrum Cannabis Extract for Chronic Pain
This AM Study Update covers the latest research on full-spectrum cannabis extract chronic pain treatment. The phase 3 trial of Cannabis sativa extract DKJ127 shows promising results for chronic low back pain. Clinicians can use this evidence to guide…
AM Study Update: March 16, 2026
This cannabis research clinical update from March 16, 2026, summarizes 20 key studies from PubMed prioritized by clinical relevance. The update covers evidence on cannabis for chronic pain, anxiety, and adolescent health. Clinicians will find valuable…
endocannabinoid system clinical research: Phase 3 Cannabis Trial
Clinical Takeaway In this phase 3 randomized controlled trial of 820 adults, the full-spectrum cannabis extract VER-01 was evaluated against placebo over 12 weeks for chronic low back pain, with long-term follow-up extending to approximately one year.…
AM Study Update: March 11, 2026
This AM Study Update highlights cannabis clinical research 2026 with 20 prioritized studies from PubMed. The update covers clinical trials and systematic reviews relevant to cannabis medicine. Clinicians will find evidence-based insights for March 11,…
Cannabinoid Clinical Trials: Full-Spectrum Cannabis for Back Pain
This phase 3 trial evaluated the full-spectrum cannabis extract for chronic low back pain in 820 adults. The study showed pain reduction and sustained benefits over 12 months. Full-spectrum cannabis extract offers a promising option for patients with…
Endocannabinoid System & Cannabis for Chronic Back Pain Trial
This phase 3 full-spectrum cannabis extract trial evaluated VER-01 for chronic low back pain in 820 adults. The study demonstrated significant pain reduction and good tolerability. These results support the potential of cannabis extract as an alternative…